ArticleAdvanced healthcare materials2025
Concurrent Biocompatibility and Antimicrobial Functionality of Soft Diamond-Like Carbon Coating for Healthcare Applications.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Silver-Doped Diamond-Like Carbon Coatings on TiACS omega · 2026Article
- Concurrent Biocompatibility and Antimicrobial Functionality of Soft Diamond-Like Carbon Coating for Healthcare Applications.Advanced healthcare materials · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This unprecedented study reveals the excellent antimicrobial performance of soft, hydrogen-free, pristine diamond-like carbon (DLC) coatings against life-threatening methicillin-resistant Staphylococcus aureus (MRSA). In addition, most previous studies have separately reported the biocompatibility and antimicrobial performance of DLC coatings, perhaps due to a nuance between antimicrobial performance and cytotoxicity. However, this work concurrently reports the biocompatibility of soft DLC with mouse fibroblast L929 cells and its antimicrobial performance against MRSA, where concurrent reporting is desirous for holistic material assessment, regulatory consideration, and enhanced safety and efficiency for biomedical applications. The soft DLC coatings are prepared with direct-current, open-field, magnetron sputtering, and characterized for structural, physical, mechanical, and electrical properties. The soft DLC coatings show excellent biocompatibility with 168 h leached extracts and antimicrobial performance after 24 h superior to copper, an established antimicrobial agent. This work proposes soft DLC as a safe material for concurrent biocompatibility and antimicrobial actions, as desired in most healthcare applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.